Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Sep;7(Suppl 6):S189.
doi: 10.21037/atm.2019.07.36.

Levodopa treatment in Parkinson's disease: earlier or later?

Federico Paolini Paoletti  1 , Nicola Tambasco  1 , Lucilla Parnetti  1
Affiliations
Editorial

Levodopa treatment in Parkinson's disease: earlier or later?

Federico Paolini Paoletti et al. Ann Transl Med. 2019 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

  • Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.
    Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA; LEAP Study Group. Verschuur CVM, et al. N Engl J Med. 2019 Jan 24;380(4):315-324. doi: 10.1056/NEJMoa1809983. N Engl J Med. 2019. PMID: 30673543 Clinical Trial.

References

    1. Olanow CW, Stocchi F. Levodopa: A new look at an old friend. Mov Disord 2018;33:859-66. 10.1002/mds.27216 - DOI - PubMed
    1. Lewitt PA. Levodopa for the treatment of Parkinson's disease. N Engl J Med 2008;359:2468-76. 10.1056/NEJMct0800326 - DOI - PubMed
    1. Warren Olanow C, Kieburtz K, Rascol O, et al. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Mov Disord 2013;28:1064-71. 10.1002/mds.25364 - DOI - PubMed
    1. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001;16:448-58. 10.1002/mds.1090 - DOI - PubMed
    1. Hely MA, Morris JG, Reid WG, et al. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-9. 10.1002/mds.20324 - DOI - PubMed